NPL Stock Overview
Provides family practice dermatology and aesthetic medical services under the NIKS brand in Singapore.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
Niks Professional Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | S$0.14 |
| 52 Week High | S$0.20 |
| 52 Week Low | S$0.13 |
| Beta | 0 |
| 11 Month Change | 4.55% |
| 3 Month Change | -4.17% |
| 1 Year Change | -30.65% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -31.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| NPL | SG Healthcare | SG Market | |
|---|---|---|---|
| 7D | -1.4% | -1.1% | -1.0% |
| 1Y | -30.7% | -15.5% | 10.1% |
Return vs Industry: NPL underperformed the SG Healthcare industry which returned -15.5% over the past year.
Return vs Market: NPL underperformed the SG Market which returned 10.1% over the past year.
Price Volatility
| NPL volatility | |
|---|---|
| NPL Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 5.7% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in SG Market | 15.1% |
| 10% least volatile stocks in SG Market | 2.4% |
Stable Share Price: NPL's share price has been volatile over the past 3 months compared to the SG market.
Volatility Over Time: Insufficient data to determine NPL's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1998 | 52 | Shoong Cheng | www.nikspro.com |
Niks Professional Ltd., together with its subsidiaries, provides family practice dermatology and aesthetic medical services under the NIKS brand in Singapore. The company operates through three segments: Clinics, Retail, and Headquarters. It offers treatment for acne and acne scars, eczema, and pigmentation, as well as non-invasive and minimally invasive aesthetic medical services, including intense pulsed light treatment, various laser treatments, and injectables.
Niks Professional Ltd. Fundamentals Summary
| NPL fundamental statistics | |
|---|---|
| Market cap | S$17.94m |
| Earnings (TTM) | S$1.52m |
| Revenue (TTM) | S$11.16m |
11.8x
P/E Ratio1.6x
P/S RatioIs NPL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NPL income statement (TTM) | |
|---|---|
| Revenue | S$11.16m |
| Cost of Revenue | S$6.91m |
| Gross Profit | S$4.25m |
| Other Expenses | S$2.73m |
| Earnings | S$1.52m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.012 |
| Gross Margin | 38.09% |
| Net Profit Margin | 13.63% |
| Debt/Equity Ratio | 0% |
How did NPL perform over the long term?
See historical performance and comparison